The African Democratic Congress (ADC) has confirmed the removal of its only National Assembly member, Hon. Leke Abejide. The decision followed the Kogi State chapter’s recommendation, accusing him of ...

Four hundred and eighty-two members of African Democratic Congress (ADC) and 53 special delegates yesterday elected ex-Speaker of Osun State House of Assembly, Dr. Najeem Salaam, as the governorship ...

TAMPA, Fla. and LONDON, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

HONOLULU (Island News) – In an effort to keep pets safe during the holiday season, the Hawaiian Humane Society (HHS) launched its Microchip Madness initiative to help families protect their ...

Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...

The Hawaiian Humane Society launched its $10 Microchip Madness initiative from Dec. 15 to Jan. 15 to help Oahu pet owners safely reunite with their animals if they go missing.

Antibody drug conjugates (ADCs) mark a new era in targeted cancer therapy, delivering potent cytotoxic chemotherapy via monoclonal antibodies directly into the tumor cells — an era with potentially ...

・Gilead will advance the clinical development and commercialization of the programs and Assembly Bio will receive a $35 million payment for Gilead’s exercise of the combined HSV program option. ・H.C.

TAMPA, Fla./LONDON - Akari Therapeutics, Plc (NASDAQ:AKTX) announced Tuesday the initiation of GMP manufacturing activities for AKTX-101, its lead antibody drug conjugate (ADC) program, partnering ...

FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its ...